Therapy | Adjusted HR (95% CI) | |
---|---|---|
Patients with end-stage cancer | Patients without end-stage cancer | |
Any antiplatelet therapy v.s. Without antiplatelet therapy | 0.13 (0.03–0.64) | 0.58 (0.26–1.26) |
Aspirin v.s. Without aspirin | 0.15 (0.03–0.74) | 0.52 (0.20–1.34) |
Clopidogrel v.s. Without clopidogrel | —a | 0.52 (0.15–1.83) |
Cilostazol v.s. Without cilostazol | —a | 3.41 (0.74–15.7) |